OculusGen Biodegradable Collagen Matrix Implant

DEVICE7 trials

Sponsors

Pro Top & Mediking Company Limited

Conditions

CataractGlaucomaGlaucomasPterygium

Phase 3

Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in Beijing Remin Hospital

CompletedNCT00321035

Pro Top & Mediking Company LimitedGlaucoma, Pterygium

Start: 2005-12-31Target: 60Updated: 2008-05-22

Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Zhong-Shan Hospital

CompletedNCT00320957

Pro Top & Mediking Company LimitedGlaucomas, Pterygium

Start: 2006-01-31End: 2006-12-31Updated: 2008-05-26

Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Beijing Hospital

CompletedNCT00320762

Pro Top & Mediking Company LimitedGlaucoma, Pterygium

Start: 2006-01-31Target: 60Updated: 2008-05-22

OculusGen-Glaucoma Historical Control Study in Taiwan

TerminatedNCT00406822

Pro Top & Mediking Company LimitedGlaucoma

Start: 2006-12-31Target: 48Updated: 2008-05-05

Ologen (OculusGen)-Glaucoma Case Control Trial in India

CompletedNCT00448929

Pro Top & Mediking Company LimitedGlaucoma

Start: 2007-01-31End: 2011-10-31Updated: 2017-06-27

Phase 4

Ologen (OculusGen)-Glaucoma MMC Control Trial in India

Pro Top & Mediking Company LimitedGlaucoma

Start: 2007-01-31End: 2011-10-31Target: 40Updated: 2011-10-07

Unknown Phase

Ologen (OculusGen)-Phacotrabeculectomy Historical Control Study in India

CompletedNCT00477685

Pro Top & Mediking Company LimitedCataract, Glaucoma

Start: 2007-05-31End: 2011-10-31Updated: 2017-08-14